Test IDs Ovarian Cancers in Which bevacizumab Is No GoodTest IDs Ovarian Cancers in Which bevacizumab Is No Good

A new gene expression test identified high-grade serous ovarian cancer (HGSOC) patients who did well after standard chemotherapy -- and who did worse if bevacizumab was added. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news